ClearPoint Neuro Inc

ClearPoint Neuro Inc

CLPT

Get informed when a big investor buys or sells

+ Follow
Market Cap$461.54M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ClearPoint Neuro IncClearPoint Neuro Inc-13--321%15.26.1
$21.00

Target Price by Analysts

38.3% upsideClearPoint Neuro Target Price DetailsTarget Price
$-10.68

Current Fair Value

170.4% downside

Overvalued by 170.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$461.54 Million
Enterprise Value$497.96 Million
Dividend Yield$- (-)
Earnings per Share$-0.9
Beta1.27
Outstanding Shares29,858,476

Return

Return on Equity-320.77%ROE
Return on Assets-39.85%
Return on Invested Capital-40.62%

Valuation & Multiples

P/E Ratio-13.04P/E Ratio
PEG-13.84PEG
Price to Sales15.18Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue11.78
Enterprise Value to EBIT-16.04
Enterprise Value to Net Income-15
Total Debt to Enterprise0.13
Debt to Equity6.11Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$-0.27
Average shareholder expectation
Revenue Estimate
$12.73 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$-0.31
Average shareholder expectation
Revenue Estimate
$12.27 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.4118 13.90%
Total Calls626,100 86.39%
Total Puts257,800 39.35%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %47.41% 3.43%
Total Invested$249.52M 110.90%
Investors Holding139 14.00%

ESG Score

No data

About ClearPoint Neuro Inc